beta blockers and glp-1 GLP-1-directed NMDA receptor antagonism for obesity treatment beta blockers and glp-1 Mapping

Adetuyi BO, Toloyai PEY, Ojugbeli ET, Oyebanjo OT, Adetuyi OA, Uche CZ, et al

Curr Top Med Chem 6 : 12051214

Theyre asking, What will this do to our budget? And for now, the budget impact is huge. Looking for smarter solutions The researchers say there are still ways to make GLP-1s a viable, affordable option, starting with smarter coverage decisions and targeted use

Gut microbiota in patients with polycystic ovary syndrome: a systematic review

Phase Reta escalation 1 Weeks 5-8 Retatrutide 4 mg/week Cagrilintide Not started Notes Continue retatrutide alone

Inclusion criteria favored randomized controlled trials, systematic reviews, and large clinical studies in peer-reviewed journals